Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study-Reference-Cited by-同舟云学术

Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study

Published:2020-04 Issue:4 Volume:19 Page:317-325
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Hagenacker Tim,Wurster Claudia D,Günther René,Schreiber-Katz Olivia,Osmanovic Alma,Petri Susanne,Weiler Markus,Ziegler Andreas,Kuttler Josua,Koch Jan C,Schneider Ilka,Wunderlich Gilbert,Schloss Natalie,Lehmann Helmar C,Cordts Isabell,Deschauer Marcus,Lingor Paul,Kamm Christoph,Stolte Benjamin,Pietruck Lena,Totzeck Andreas,Kizina Kathrin,Mönninghoff Christoph,von Velsen Otgonzul,Ose Claudia,Reichmann Heinz,Forsting Michael,Pechmann Astrid,Kirschner Janbernd,Ludolph Albert C,Hermann Andreas,Kleinschnitz Christoph

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference21 articles.

1. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens;Sugarman;Eur J Hum Genet,2012

2. Spinal muscular atrophy;Lunn;Lancet,2008

3. Identification and characterization of a spinal muscular atrophy-determining gene;Lefebvre;Cell,1995

4. Correlation between severity and SMN protein level in spinal muscular atrophy;Lefebvre;Nat Genet,1997

5. Nusinersen versus sham control in infantile-onset spinal muscular atrophy;Finkel;N Engl J Med,2017

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy;Journal of Neuromuscular Diseases;2024-09-03

2. Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis;Neurology and Therapy;2024-09-02

3. Cytokines in cerebrospinal fluid as a prognostic predictor after treatment of nusinersen in SMA patients;Clinical Neurology and Neurosurgery;2024-09

4. Nusinersen Improves Motor Function in Type 2 and 3 Spinal Muscular Atrophy Patients across Time;Biomedicines;2024-08-06

5. Six‐minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen;Muscle & Nerve;2024-08-02